Company / Current Assets
Relay Therapeutics, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$578.3M
FY2025
5-year range
$578.3M / $1.0B
FY2021-FY2025
Trend
-28.5%
vs FY2024
Sector context
#102 of 213
Health Care
What the data says
At $578M, Relay Therapeutics, Inc.'s current assets ranks #102 of 213 in the Health Care sector. Current Assets has fluctuated over the past 7 years, ranging from $361M in FY2019 to $1.0B in FY2022.
Based on SEC 10-K filings.
$578M in FY2025 with a 5-year CAGR of -5.6%.
Declined from $770M to $578M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -17.2%
- 5-Year CAGR
- -5.6%
- 10-Year CAGR
- -
Sector benchmark
#102 of 213 in Health CareTop 48% of 213This company $578.3M Sector average $2.5B
▼
-77.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.6%, indicating a declining trend.
- In FY2025, current assets decreased 28.5% year-over-year.
- Ranks #102 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $578.3M | -28.5% |
| FY2024 | $809.2M | +5.1% |
| FY2023 | $770.1M | -24.5% |
| FY2022 | $1.0B | +4.4% |
| FY2021 | $976.2M | +26.8% |
| FY2020 | $770.1M | +113.6% |
| FY2019 | $360.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026